Latest filing published 05 Nov 2026 for UNITED THERAPEUTICS Corp, €4.4M.
Insider track record
Paul Mahon: trading record in brief
Paul Mahon discloses dealings in UNITED THERAPEUTICS Corp to SEC (Form 4). Over a trading history stretching from 4 June 2026 to 5 November 2026, the count stands at 10 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 5 November 2026, the filings show a transaction worth €4.4M in UNITED THERAPEUTICS Corp. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul Mahon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,300 shares@ US$598.6666CommonSEC144:0001950047-26-010730
- 8,300 shares@ US$544.30230.020% mcap11.7% of flowCommonSEC144:0001950047-26-010252
- 8,300 shares@ US$564.94590.022% mcap13.6% of flowCommonSEC144:0001950047-26-009919
- 8,300 shares@ US$497.54310.018% mcap10.4% of flowCommonSEC144:0001950047-26-009611
- 8,300 shares@ US$482.02850.015% mcap10.0% of flowCommonSEC144:0001950047-26-009046
- 8,300 shares@ US$523.1420.016% mcap10.8% of flowCommonSEC144:0001950047-26-008497
- 8,300 shares@ US$517.04970.021% mcap14.1% of flowCommonSEC144:0001950047-26-007724
- 8,300 shares@ US$552.56320.022% mcap15.2% of flowCommonSEC144:0001950047-26-006813
- 8,300 shares@ US$541.54710.019% mcap14.9% of flowCommonSEC144:0001950047-26-006307
- 8,300 shares@ US$547.06540.019% mcap14.9% of flowCommonSEC144:0001950047-26-005618
10 of 10 declarations
